SEC Form 4 · accession 0001203311-19-000006
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Todd E Simpson
Officer — Chief Financial Officer
Period of report
Mar 4, 2019
Accepted (ET)
Mar 6, 2019 · 6:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 4, 2019 | S | 10,000 | $75.00 | D | 184,280 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- F2Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 359 shares acquired under the Amended and Restated 2000 Employee Stock Purchase Plan on January 31, 2019.